ES522561A0 - Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. - Google Patents

Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Info

Publication number
ES522561A0
ES522561A0 ES522561A ES522561A ES522561A0 ES 522561 A0 ES522561 A0 ES 522561A0 ES 522561 A ES522561 A ES 522561A ES 522561 A ES522561 A ES 522561A ES 522561 A0 ES522561 A0 ES 522561A0
Authority
ES
Spain
Prior art keywords
cyclical
procedure
preparation
peptidic derivative
peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522561A
Other languages
English (en)
Other versions
ES8407012A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8407012A1 publication Critical patent/ES8407012A1/es
Publication of ES522561A0 publication Critical patent/ES522561A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62Streptosporangium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES522561A 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. Granted ES522561A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,498 US4399067A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (2)

Publication Number Publication Date
ES8407012A1 ES8407012A1 (es) 1984-09-01
ES522561A0 true ES522561A0 (es) 1984-09-01

Family

ID=23501401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522561A Granted ES522561A0 (es) 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Country Status (15)

Country Link
US (1) US4399067A (es)
KR (1) KR860002185B1 (es)
AT (1) AT380022B (es)
CA (1) CA1215043A (es)
DD (1) DD209810A5 (es)
DK (1) DK220983A (es)
EG (1) EG16042A (es)
ES (1) ES522561A0 (es)
FI (1) FI831746L (es)
GR (1) GR79259B (es)
HU (1) HU192955B (es)
PH (1) PH21382A (es)
PL (1) PL242096A1 (es)
PT (1) PT76701B (es)
RO (1) RO86721B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315229C (en) * 1987-06-10 1993-03-30 Patrick J. Baker Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
AU784942B2 (en) * 1999-12-15 2006-08-03 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
US7408025B2 (en) * 1999-12-15 2008-08-05 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
KR20020063227A (ko) 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 신규한 리포펩티드
EP1423414A4 (en) 2001-08-06 2005-11-30 Cubist Pharm Inc NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
PT2379580E (pt) * 2008-12-22 2014-01-20 Cubist Pharm Inc Novos agentes antibacterianos para o tratamento de infecções por bactérias gram positivas
TW201035111A (en) 2008-12-23 2010-10-01 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus

Also Published As

Publication number Publication date
KR860002185B1 (ko) 1986-12-24
DK220983A (da) 1983-11-22
AT380022B (de) 1986-03-25
RO86721A (ro) 1985-04-17
PT76701B (en) 1986-03-27
ES8407012A1 (es) 1984-09-01
ATA178383A (de) 1985-08-15
DD209810A5 (de) 1984-05-23
CA1215043A (en) 1986-12-09
GR79259B (es) 1984-10-22
HU192955B (en) 1987-08-28
KR840005076A (ko) 1984-11-03
EG16042A (en) 1986-12-30
PH21382A (en) 1987-10-15
US4399067A (en) 1983-08-16
PL242096A1 (en) 1984-07-02
RO86721B (ro) 1985-05-01
FI831746A0 (fi) 1983-05-18
FI831746L (fi) 1983-11-22
DK220983D0 (da) 1983-05-18
PT76701A (en) 1983-06-01

Similar Documents

Publication Publication Date Title
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES533097A0 (es) Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ES513935A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES520783A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES519735A0 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ES522561A0 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
MX158194A (es) Procedimiento para la preparacion del sesquihidrato de un derivado de naftiridina
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES520866A0 (es) Un procedimiento para la preparacion del complejo a41030.
ES516929A0 (es) Un procedimiento para la preparacion de etilenglicol.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES535727A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES526528A0 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
ES530212A0 (es) Un procedimiento para la produccion de un derivado de 2-amino-tiazol.
ES519734A0 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ES518809A0 (es) Un procedimiento para la preparacion de un alergeno modificado.
ES508845A0 (es) Un procedimiento para la preparacion de un derivado de nitrosourea.
ES521195A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES520076A0 (es) Un procedimiento para la preparacion de pirropirroles.
ES510448A0 (es) Un procedimiento para la preparacion azaespiroalcanodionas.
ES520338A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos.